Corteva, Inc. (NYSE:CTVA) Shares Purchased by NTV Asset Management LLC

NTV Asset Management LLC lifted its stake in Corteva, Inc. (NYSE:CTVA) by 6.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,450 shares of the company’s stock after purchasing an additional 320 shares during the period. NTV Asset Management LLC’s holdings in Corteva were worth $314,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Forsta AP Fonden increased its holdings in Corteva by 8.1% during the 1st quarter. Forsta AP Fonden now owns 141,900 shares of the company’s stock valued at $8,183,000 after acquiring an additional 10,600 shares in the last quarter. Illinois Municipal Retirement Fund increased its holdings in Corteva by 295.9% during the 1st quarter. Illinois Municipal Retirement Fund now owns 94,896 shares of the company’s stock valued at $5,473,000 after acquiring an additional 70,924 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in shares of Corteva by 1.3% during the first quarter. Oppenheimer Asset Management Inc. now owns 24,212 shares of the company’s stock worth $1,396,000 after buying an additional 305 shares in the last quarter. Hilltop National Bank purchased a new stake in shares of Corteva during the first quarter worth about $195,000. Finally, SG Americas Securities LLC grew its holdings in shares of Corteva by 279.5% during the first quarter. SG Americas Securities LLC now owns 120,952 shares of the company’s stock worth $6,975,000 after buying an additional 89,077 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Up 1.6 %

Shares of NYSE:CTVA traded up $0.83 during midday trading on Friday, reaching $53.10. The company had a trading volume of 2,495,994 shares, compared to its average volume of 2,866,087. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.51 and a quick ratio of 0.97. The stock’s fifty day moving average price is $54.16 and its 200-day moving average price is $53.14. The stock has a market capitalization of $37.01 billion, a P/E ratio of 67.22, a PEG ratio of 1.42 and a beta of 0.77. Corteva, Inc. has a one year low of $43.22 and a one year high of $58.76.

Corteva (NYSE:CTVA) last released its earnings results on Wednesday, May 1st. The company reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.10. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The firm had revenue of $4.49 billion during the quarter, compared to analyst estimates of $4.65 billion. During the same quarter in the previous year, the firm earned $1.16 earnings per share. The firm’s revenue for the quarter was down 8.0% compared to the same quarter last year. Equities research analysts expect that Corteva, Inc. will post 2.79 earnings per share for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Shareholders of record on Tuesday, June 4th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Tuesday, June 4th. This represents a $0.64 annualized dividend and a yield of 1.21%. Corteva’s payout ratio is 81.01%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on CTVA shares. Oppenheimer lifted their price target on shares of Corteva from $67.00 to $69.00 and gave the stock an “outperform” rating in a report on Friday, May 3rd. Mizuho decreased their target price on shares of Corteva from $61.00 to $60.00 and set a “buy” rating on the stock in a research report on Tuesday, June 18th. BMO Capital Markets raised their target price on shares of Corteva from $64.00 to $67.00 and gave the stock an “outperform” rating in a research report on Friday, May 3rd. OTR Global reissued a “negative” rating on shares of Corteva in a research report on Friday, June 7th. Finally, Royal Bank of Canada lifted their price target on shares of Corteva from $62.00 to $64.00 and gave the company an “outperform” rating in a research report on Monday, May 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and a consensus price target of $63.00.

Insider Buying and Selling at Corteva

In other news, SVP Cornel B. Fuerer sold 39,736 shares of the company’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total transaction of $2,281,243.76. Following the completion of the transaction, the senior vice president now owns 126,628 shares in the company, valued at $7,269,713.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Corteva news, insider Samuel R. Eathington sold 31,686 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $57.64, for a total value of $1,826,381.04. Following the completion of the sale, the insider now directly owns 53,854 shares of the company’s stock, valued at approximately $3,104,144.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Cornel B. Fuerer sold 39,736 shares of the business’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $57.41, for a total value of $2,281,243.76. Following the sale, the senior vice president now owns 126,628 shares in the company, valued at approximately $7,269,713.48. The disclosure for this sale can be found here. Insiders sold a total of 83,556 shares of company stock worth $4,795,016 over the last 90 days. Insiders own 0.14% of the company’s stock.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.